One man's stomach cancer that spread to his brain went away after focused radiation and two drugs
Original title: Complete and durable remission in a patient with brain metastasis from gastric cancer treated with SRS followed by RC48 plus camrelizumab after progression on chemo-immunotherapy: a case report and literature review.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was seen in only one patient and has not been tested in a trial.
The short version
Doctors describe one man whose cancer that had spread to his brain went away and has stayed away for over three years.
What was studied. This report is about one 52-year-old man. His stomach cancer had spread to his brain. Doctors also looked back at past research on similar treatments.
What they found. His cancer grew again after his first treatment, and it spread to his brain. He then got focused radiation to the one spot in his brain. After that, he took two drugs, RC48 and camrelizumab, for eight months. He stopped because of lung swelling. Later, his scans showed no signs of cancer. He has been off treatment for over three years and is still cancer-free.
What this means, and what it doesn't
What it could mean: For some people whose stomach cancer has spread to the brain, this mix of radiation and drugs may be worth studying more. It gives doctors an idea to test in more patients.
What it doesn't mean: This is the story of just one person. It does not prove the treatment works for others. It has not been tested in a trial. It is not standard care for brain tumors. It is not a cure, and it is not a promise that others will have the same result.
Source: PubMed, September 3, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.